Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Recent News

View:

Post by SkywalkerofLuke on Mar 07, 2023 3:39pm

Recent News

AGN announced last week that its subsidiary Algernon NeuroScience appointed Dr. David L. Brody as a consultant for its clinical research program for the treatment of Traumatic Brain Injury with DMT.

Key highlights

- Washington University site director for the National Football League (NFL) Neurological player care program

- Board-certified neurologist with both a research and a clinical specialization in TBI and neurodegenerative diseases

- Professor of Neurology at the Washington University School of Medicine in St. Louis

AGN Neuro is planning to be the first company globally to investigate DMT for TBI in humans and is working towards a Phase 2 clinical trial in Q4.

https://ir.algernonpharmaceuticals.com/news-events/press-releases/detail/177/algernon-neuroscience-appoints-global-tbi-expert-and-former

105